Home Compare BIIB vs MDT
Stock Comparison · Structural lead, mixed market

Biogen vs Medtronic: Which Stock Looks Stronger in 2026?

Medtronic holds the cleaner structural position, with the lead spread across stability and growth. Biogen does not offset that deficit through any equally strong structural edge elsewhere. In the market, Biogen carries the stronger setup — intact trend against Medtronic's broken trend. That leaves a split case: the structural lead stays with Medtronic, but the market is not currently confirming it.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across stability and growth, rather than sitting in one isolated gap. Medtronic plc leads by 25 points on the overall comparison score.

Trajectory Similarity
0.73
Similar
Peer-set rank: #1
within Biogen Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.

Most of the shared profile comes through revenue stability and investment intensity.

Similarity drivers
revenue stabilityinvestment intensity
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BIIB
Biogen Inc.
26
Peer-Score
Signal qualityHigh
vs
MDT
Medtronic plc
51
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The largest gaps do not all point in the same direction.

Dimension spread: BIIB vs MDT Profitability 0 24 Stability 10 72 Valuation 80 74 Growth 0 33 BIIB MDT
Gap Ranking
#1 Stability +62
#2 Growth +33
#3 Profitability +24
#4 Valuation +6
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BIIB and MDT Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BIIBMDT Relative valuation Structural strength

Medtronic plc occupies the cheaper side of the setup map, although Biogen Inc. still holds the stronger structural profile.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Stability
Medtronic plc ranks near the top of the group on stability; Biogen Inc. sits in the weaker half.
Growth
Both sit in the weaker half on growth, with Medtronic plc still coming out ahead.
Stability — Dominant Gap
BIIB
10
MDT
72
Gap+62in favour of MDT

The stability gap is very wide, with the stronger side looking materially steadier through time.

What keeps the gap from being one-sided

On the market side, Biogen carries the stronger trend while Medtronic's trend has broken — the market setup does not confirm the structural advantage.

What this means for the comparison

The lead is built on both stability and growth, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the BIIB vs MDT comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar stability-driven comparisons

Explore how BIIB and MDT each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.